QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
NASDAQ:BIOS

BioPlus Acquisition (BIOS) Stock Forecast, Price & News

$10.83
-0.01 (-0.09%)
(As of 09/28/2023 ET)
Compare
Today's Range
$10.83
$10.83
50-Day Range
$10.65
$10.84
52-Week Range
$10.05
$11.68
Volume
327 shs
Average Volume
126,249 shs
Market Capitalization
$209.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BIOS stock logo

About BioPlus Acquisition (NASDAQ:BIOS) Stock

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

BIOS Price History

BIOS Stock News Headlines

U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
BIOS BioPlus Acquisition Corp.
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
BioPlus Acquisition Corp - Ordinary Shares - Class A
BioPlus Acquisition Corp. Cl A
BioPlus Acquisition Corp. (BIOS)
BioPlus Acquisition Corp (BIOS)
BioPlus Acquisition Corp
See More Headlines
Receive BIOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOS Company Calendar

Today
9/28/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
14,990,000
Market Cap
$209.78 million
Optionable
Not Optionable
Beta
0.02
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Jonathan M. N. Rigby MBA (Age 55)
    Chairman & Chief Bus. Officer
  • Mr. R. Ross Haghighat (Age 59)
    CEO, CFO & Director













BIOS Stock - Frequently Asked Questions

How have BIOS shares performed in 2023?

BioPlus Acquisition's stock was trading at $10.22 on January 1st, 2023. Since then, BIOS stock has increased by 6.0% and is now trading at $10.83.
View the best growth stocks for 2023 here
.

Are investors shorting BioPlus Acquisition?

BioPlus Acquisition saw a decline in short interest in September. As of September 15th, there was short interest totaling 1,600 shares, a decline of 36.0% from the August 31st total of 2,500 shares. Based on an average daily trading volume, of 40,000 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the company's shares are short sold.
View BioPlus Acquisition's Short Interest
.

What ETF holds BioPlus Acquisition's stock ?

CrossingBridge Pre-Merger SPAC ETF holds 29,741 shares of BIOS stock, representing 0.48% of its portfolio.

When did BioPlus Acquisition IPO?

(BIOS) raised $180 million in an IPO on Friday, December 3rd 2021. The company issued 18,000,000 shares at a price of $10.00 per share. Cantor acted as the underwriter for the IPO.

What is BioPlus Acquisition's stock symbol?

BioPlus Acquisition trades on the NASDAQ under the ticker symbol "BIOS."

Who are BioPlus Acquisition's major shareholders?

BioPlus Acquisition's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Westchester Capital Management LLC (4.74%), Mizuho Securities USA LLC (3.46%), Radcliffe Capital Management L.P. (2.45%), Berkley W R Corp (2.04%), Wolverine Asset Management LLC (1.65%) and Quarry LP (1.55%).

How do I buy shares of BioPlus Acquisition?

Shares of BIOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BioPlus Acquisition's stock price today?

One share of BIOS stock can currently be purchased for approximately $10.83.

How much money does BioPlus Acquisition make?

BioPlus Acquisition (NASDAQ:BIOS) has a market capitalization of $209.78 million.

How can I contact BioPlus Acquisition?

BioPlus Acquisition's mailing address is 260 MADISON AVENUE SUITE 800, NEW YORK NY, 10016. The official website for the company is bioplusspac.com. The company can be reached via phone at 212-287-4092.

This page (NASDAQ:BIOS) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -